S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
LON:RENX

Renalytix (RENX) Share Price, News & Analysis

GBX 33.50
-1.50 (-4.29%)
(As of 03/28/2024 ET)
Today's Range
33.50
33.50
50-Day Range
10
50.40
52-Week Range
10
150
Volume
92,711 shs
Average Volume
687,626 shs
Market Capitalization
£40.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
RENX stock logo

About Renalytix Stock (LON:RENX)

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix Plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; and Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is based in New York, New York.

RENX Stock Price History

RENX Stock News Headlines

Renalytix (LON:RENX) Trading Up 6%
Is Renalytix the best penny stock to buy today?
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
RNLX Mar 2024 2.500 call
Renalytix AI plc (RENX)
Renalytix PLC RENX
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Renalytix Reports Full Year Fiscal 2023 Results
Renalytix announces a c.$20.3 million private placement
See More Headlines
Receive RENX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
102
Year Founded
N/A

Profitability

Net Income
£-41,850,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£2.41 million
Cash Flow
GBX 18.25 per share
Book Value
GBX (8) per share

Miscellaneous

Free Float
N/A
Market Cap
£40.17 million
Optionable
Not Optionable
Beta
1.92
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. James R. McCullough M.B.A. (Age 56)
    Chief Executive Officer
    Comp: $809.57k
  • Mr. Thomas H. McLain CPA (Age 65)
    M.B.A, President
    Comp: $517.7k
  • Mr. Oliver James Sterling III
    Chief Financial Officer
  • Mr. Fergus Fleming (Age 56)
    Chief Technology Officer
  • Dr. Michael J. Donovan M.D. (Age 69)
    Ph.D., Chief Medical Officer
  • Mr. Howard B. Doran Jr. (Age 63)
    Chief Business Officer
  • Mr. Salim Gulamabbas Hamir F.C.A.
    Company Secretary

RENX Stock Analysis - Frequently Asked Questions

How have RENX shares performed in 2024?

Renalytix's stock was trading at GBX 15.50 at the beginning of the year. Since then, RENX shares have increased by 116.1% and is now trading at GBX 33.50.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Renalytix own?
How do I buy shares of Renalytix?

Shares of RENX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:RENX) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners